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KDM6B Elicits Cell Apoptosis by Promoting Nuclear Translocation of FOXO1 in NonSmall Cell Lung Cancer

Introduction
Lung cancer is one of the most common malignancies and the leading cause of cancerrelated deaths in the world [1, 2] . Non-small cell lung carcinoma (NSCLC) is the most common histological type of lung cancer and accounts for more than 85% of the cases [3] . The main types of NSCLC are adenocarcinoma and squamous cell carcinoma [4] . Although some advanced treatment techniques have been developed, the 5-year survival rate of patients with NSCLC remains poor [5] . Moreover, the molecular mechanisms involved in NSCLC are poorly understood. Therefore, it is necessary to identify novel genes that participate in regulating the progression and development of NSCLC.
The development of tumors often results from an imbalance between cell proliferation and apoptosis. Apoptosis plays a negative regulatory role that acts against the initiation and progression of cancer. Genes associated with the regulation of apoptosis are considered to be a new class of tumor-related genes [6] . Histone methylation, which is regulated by histone methyltransferases and demethylases, participates in the regulation of transcriptional repression and activation during both normal embryonic development and carcinogenic progression [7, 8] . Multiple cellular functions, including cell proliferation, apoptosis and differentiation, are affected by histone methylation. Previous studies have shown that some histone methyltransferases and demethylases are closely related to cell growth, metastasis and apoptosis during the progression and development of cancer [9] [10] [11] .
The trimethylation of lysine 27 of histone H3 (H3K27me3) is an important function an oncogene, enhances tumorigenesis and promotes the development of tumors in patients with Hodgkin's lymphoma, breast carcinoma, and renal cell carcinoma [14] [15] [16] . Currently,
Materials and Methods
Cell culture
The human NSCLC cell lines A549, H460, H1299, SK-MES-1, H1650, H292, and H358 were purchased from American Tissue Culture Collection 2 atmosphere at 37 °C.
Western blot assay
Cell proteins were extracted with the T-PER tissue protein extraction reagent (Pierce, Rockford, IL) containing the appropriate concentrations of proteinase inhibitors and phosphatase inhibitors (Tris 20 mM, pH 7.6, NaCl 150 mM, and Tween 20 0.1%) containing 5% nonfat dry milk powder, the at 4°C, followed by reaction with HRP-conjugated secondary antibodies for 1 h at room temperature and enhanced chemiluminescence reagents, protein bands were visualized using chemiluminescence detection. 
LDH release assay
absorbance was then measured at 440 nm using a spectrophotometer. Sister cultures were treated with a using medium containing Triton-lysed cellular supernatant. chamber. After an optimal incubation time, we used a cotton swab to remove non-migrated and non-invaded cells from the upper chamber. The migrated or invaded cells were stained with crystal violet (1% in methyl alcohol) for 10 min. 
Migration and invasion assays
Mitochondrial membrane potentials assay
